Pharmacokinetic analysis of [18F]FAZA in non-small cell lung cancer patients. (Q53120502)

11 May 2018

title

Pharmacokinetic analysis of [18F]FAZA in non-small cell lung cancer patients. (English)

1 reference

11 May 2018

1 reference

6

1 reference

11 May 2018

Ronald Boellaard

10

1 reference

11 May 2018

Adriaan A Lammertsma

Adriaan A Lammertsma

8

0 references

Robert C Schuit

5

Robert C Schuit

1 reference

11 May 2018

Pieter G Raijmakers

7

Pieter Raijmakers

1 reference

11 May 2018

Eline E Verwer

1

Eline E Verwer

1 reference

11 May 2018

Idris Bahce

3

Idris Bahce

1 reference

11 May 2018

Floris H P van Velden

2

Floris H P van Velden

1 reference

11 May 2018

Egbert F Smit

9

Egbert F Smit

1 reference

11 May 2018

Maqsood Yaqub

4

Maqsood Yaqub

1 reference

11 May 2018

publication date

6 June 2013

1 reference

11 May 2018

European Journal of Nuclear Medicine and Molecular Imaging

published in

1 reference

11 May 2018

volume

40

1 reference

11 May 2018

issue

10

1 reference

11 May 2018

page(s)

1523-1531

1 reference

11 May 2018

Hypoxia in cancer: significance and impact on clinical outcome

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2462-3

Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation O

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2462-3

Pretreatment 18F-FAZA PET predicts success of hypoxia-directed radiochemotherapy using tirapazamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2462-3

Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2462-3

Can hypoxia-PET map hypoxic cell density heterogeneity accurately in an animal tumor model at a clinically obtainable image contrast?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2462-3

Hypoxia positron emission tomography imaging with 18f-fluoromisonidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2462-3

Nitroimidazoles and imaging hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2462-3

18FFluoroazomycinarabinofuranoside (18FAZA) and 18FFluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2462-3

Investigation on tumor hypoxia in resectable primary prostate cancer as demonstrated by 18F-FAZA PET/CT utilizing multimodality fusion techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2462-3

Tumour hypoxia imaging with [18F]FAZA PET in head and neck cancer patients: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2462-3

Evaluating repetitive 18F-fluoroazomycin-arabinoside (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2462-3

Assessing hypoxia in animal tumor models based on pharmocokinetic analysis of dynamic FAZA PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2462-3

Quantitative assessment of hypoxia kinetic models by a cross-study of dynamic 18F-FAZA and 15O-H2O in patients with head and neck tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2462-3

Preparation of the hypoxia imaging PET tracer [18F]FAZA: reaction parameters and automation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2462-3

Standards for PET image acquisition and quantitative data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2462-3

FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2462-3

Characteristics of a new fully programmable blood sampling device for monitoring blood radioactivity during PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2462-3

Positron emission tomography compartmental models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2462-3

Optimization algorithms and weighting factors for analysis of dynamic PET studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2462-3

Comparison of methods for analysis of clinical [11C]raclopride studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2462-3

A new look at the statistical model identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2462-3

Reevaluation of the standardized uptake value for FDG: variations with body weight and methods for correction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2462-3

Computerized method for automatic evaluation of lean body mass from PET/CT: comparison with predictive equations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2462-3

Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2462-3

Significant impact of different oxygen breathing conditions on noninvasive in vivo tumor-hypoxia imaging using [¹⁸F]-fluoro-azomycinarabino-furanoside ([¹⁸F]FAZA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2462-3

Impact of [¹⁸F]FDG PET imaging parameters on automatic tumour delineation: need for improved tumour delineation methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2462-3

Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2462-3

Molecular Imaging of Hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2462-3

Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside.

21 January 2018

1 reference

12 December 2020

Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy.

1 reference

12 December 2020

Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA--first small animal PET results.

1 reference

12 December 2020

Choosing the optimal fit function: comparison of the Akaike information criterion and the F-test

1 reference

12 December 2020

Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients

1 reference

12 December 2020

Hypoxia PET/CT imaging: implications for radiation oncology

1 reference

12 December 2020

10.1007/S00259-013-2462-3

Identifiers

DOI

1 reference

11 May 2018

1 reference

11 May 2018